218 related articles for article (PubMed ID: 31566583)
1. FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans.
Du Q; Huynh LK; Coskun F; Molina E; King MA; Raj P; Khan S; Dozmorov I; Seroogy CM; Wysocki CA; Padron GT; Yates TR; Markert ML; de la Morena MT; van Oers NS
J Clin Invest; 2019 Nov; 129(11):4724-4738. PubMed ID: 31566583
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive phenotypic analysis of diverse FOXN1 variants.
Moses A; Bhalla P; Thompson A; Lai L; Coskun FS; Seroogy CM; de la Morena MT; Wysocki CA; van Oers NSC
J Allergy Clin Immunol; 2023 Nov; 152(5):1273-1291.e15. PubMed ID: 37419334
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis.
Bosticardo M; Yamazaki Y; Cowan J; Giardino G; Corsino C; Scalia G; Prencipe R; Ruffner M; Hill DA; Sakovich I; Yemialyanava I; Tam JS; Padem N; Elder ME; Sleasman JW; Perez E; Niebur H; Seroogy CM; Sharapova S; Gebbia J; Kleiner GI; Peake J; Abbott JK; Gelfand EW; Crestani E; Biggs C; Butte MJ; Hartog N; Hayward A; Chen K; Heimall J; Seeborg F; Bartnikas LM; Cooper MA; Pignata C; Bhandoola A; Notarangelo LD
Am J Hum Genet; 2019 Sep; 105(3):549-561. PubMed ID: 31447097
[TBL] [Abstract][Full Text] [Related]
4. FoxN1-dependent thymic epithelial cells promote T-cell leukemia development.
Ghezzo MN; Fernandes MT; Pacheco-Leyva I; Rodrigues PM; Machado RS; Araújo MAS; Kalathur RK; Futschik ME; Alves NL; Dos Santos NR
Carcinogenesis; 2018 Dec; 39(12):1463-1476. PubMed ID: 30256907
[TBL] [Abstract][Full Text] [Related]
5. FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program.
Romano R; Palamaro L; Fusco A; Giardino G; Gallo V; Del Vecchio L; Pignata C
Front Immunol; 2013; 4():187. PubMed ID: 23874334
[TBL] [Abstract][Full Text] [Related]
6. Human clinical phenotype associated with FOXN1 mutations.
Pignata C; Fusco A; Amorosi S
Adv Exp Med Biol; 2009; 665():195-206. PubMed ID: 20429426
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg
Wei X; Lai Y; Li B; Qin L; Xu Y; Lin S; Wang S; Wu Q; Liang Q; Huang G; Deng Q; Liu P; Wu D; Lai L; Yao Y; Li P
Sci Rep; 2017 Aug; 7(1):7720. PubMed ID: 28798321
[TBL] [Abstract][Full Text] [Related]
8. Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations.
Giardino G; Sharapova SO; Ciznar P; Dhalla F; Maragliano L; Radha Rama Devi A; Islamoglu C; Ikinciogullari A; Haskologlu S; Dogu F; Hanna-Wakim R; Dbaibo G; Chou J; Cirillo E; Borzacchiello C; Kreins AY; Worth A; Rota IA; Marques JG; Sayitoglu M; Firtina S; Mahdi M; Geha R; Neven B; Sousa AE; Benfenati F; Hollander GA; Davies EG; Pignata C
J Clin Immunol; 2021 May; 41(4):756-768. PubMed ID: 33464451
[TBL] [Abstract][Full Text] [Related]
9. FOXN1 in organ development and human diseases.
Palamaro L; Romano R; Fusco A; Giardino G; Gallo V; Pignata C
Int Rev Immunol; 2014 Mar; 33(2):83-93. PubMed ID: 24432845
[TBL] [Abstract][Full Text] [Related]
10. FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches.
Gallo V; Cirillo E; Giardino G; Pignata C
J Clin Immunol; 2017 Nov; 37(8):751-758. PubMed ID: 28932937
[TBL] [Abstract][Full Text] [Related]
11. Foxn1 is required to maintain the postnatal thymic microenvironment in a dosage-sensitive manner.
Chen L; Xiao S; Manley NR
Blood; 2009 Jan; 113(3):567-74. PubMed ID: 18978204
[TBL] [Abstract][Full Text] [Related]
12. Morphogenesis and maintenance of the 3D thymic medulla and prevention of nude skin phenotype require FoxN1 in pre- and post-natal K14 epithelium.
Guo J; Rahman M; Cheng L; Zhang S; Tvinnereim A; Su DM
J Mol Med (Berl); 2011 Mar; 89(3):263-77. PubMed ID: 21109991
[TBL] [Abstract][Full Text] [Related]
13. FOXN1 mutation abrogates prenatal T-cell development in humans.
Vigliano I; Gorrese M; Fusco A; Vitiello L; Amorosi S; Panico L; Ursini MV; Calcagno G; Racioppi L; Del Vecchio L; Pignata C
J Med Genet; 2011 Jun; 48(6):413-6. PubMed ID: 21507891
[TBL] [Abstract][Full Text] [Related]
14. Hypomorphic phenotype of Foxn1 gene-modified rats by CRISPR/Cas9 system.
Goto T; Hara H; Nakauchi H; Hochi S; Hirabayashi M
Transgenic Res; 2016 Aug; 25(4):533-44. PubMed ID: 26931321
[TBL] [Abstract][Full Text] [Related]
15. From murine to human nude/SCID: the thymus, T-cell development and the missing link.
Romano R; Palamaro L; Fusco A; Iannace L; Maio S; Vigliano I; Giardino G; Pignata C
Clin Dev Immunol; 2012; 2012():467101. PubMed ID: 22474479
[TBL] [Abstract][Full Text] [Related]
16. Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndrome.
Bernstock JD; Totten AH; Elkahloun AG; Johnson KR; Hurst AC; Goldman F; Groves AK; Mikhail FM; Atkinson TP
J Allergy Clin Immunol; 2020 Jan; 145(1):358-367.e2. PubMed ID: 31600545
[TBL] [Abstract][Full Text] [Related]
17. A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation.
Su DM; Navarre S; Oh WJ; Condie BG; Manley NR
Nat Immunol; 2003 Nov; 4(11):1128-35. PubMed ID: 14528302
[TBL] [Abstract][Full Text] [Related]
18. Foxn1 overexpression promotes thymic epithelial progenitor cell proliferation and mTEC maintenance, but does not prevent thymic involution.
Li J; Wachsmuth LP; Xiao S; Condie BG; Manley NR
Development; 2023 Apr; 150(8):. PubMed ID: 36975725
[TBL] [Abstract][Full Text] [Related]
19. Biological significance of FoxN1 gain-of-function mutations during T and B lymphopoiesis in juvenile mice.
Ruan L; Zhang Z; Mu L; Burnley P; Wang L; Coder B; Zhuge Q; Su DM
Cell Death Dis; 2014 Oct; 5(10):e1457. PubMed ID: 25299782
[TBL] [Abstract][Full Text] [Related]
20. FOXN1 Italian founder mutation in Indian family: Implications in prenatal diagnosis.
Radha Rama Devi A; Panday NN; Naushad SM
Gene; 2017 Sep; 627():222-225. PubMed ID: 28636882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
